October 2013
Table of Contents

Funding Opportunities

Highlighted positions related to cancer for which VCU is currently hiring. View the full list. 

Shared Resource Spotlight 

Genomics Developing Shared Resource Core

The mission of GDSRC is to make available to researchers the cutting-edge tools necessary for modern genomic analysis. The primary focus of this core is providing access to Next-Generation (NextGen) DNA sequencing and analysis capabilities.

Research HighlightsHighlights
Paul Dent, Ph.D.
Developmental Therapeutics
Drug combination therapy causes cancer cells to "eat themselves"

A recent preclinical study has confirmed that a combination of sorafenib, regorafenib and PI3K/AKT inhibitors synergize to kill a variety of cancers. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients. 

Center News Center1
Massey's BMT unit first of its kind in nation to receive prestigious Beacon Award


The inpatient bone marrow transplant (BMT) unit at Massey is the first of its kind in the nation to earn the American Association of Critical-Care Nurses (AACN) Beacon Award for Excellence, which recognizes individual units that distinguish themselves by improving every facet of patient care. This highly regarded award is a significant achievement for a hospital unit and signifies a commitment to patient safety and satisfaction. 


Massey first in Richmond to offer cutting-edge therapy for metastatic prostate cancer


Massey is the only cancer care provider in the Richmond metropolitan region to offer radium-223, an innovative, new drug that has been shown to increase survival and quality of life in patients with metastatic castration-resistant prostate cancer (CRPC).  


Member ShowcaseShowcase
Margaret A. Park, Ph.D.
Cancer Cell Signaling
Park studies RNA splicing
Massey welcomes Margaret A. Park, Ph.D., as a new member of the Cancer Cell Signaling program. Her research interests are in RNA splicing, especially as it relates to metastasis and related pathways, cell death and autophagy regulation, cell signaling, combination inhibitor therapies for cancer and systems biology. 

Park is also a Center for Clinical and Translational Research KL2 Scholar award recipient.  
Researcher Recognition Recognition
Krist receives NIH grant to study a new system for cancer screenings

Alex Krist, M.P.H., M.D. 
Cancer Prevention and Control  member

Alex Krist, M.P.H., M.D., has received a multi-year, multi-phase grant from the National Institutes of Health (NIH) to measure whether making personal health records with higher functionality available to primary care physicians and patients will promote shared health decision-making and increase the use of cancer screening compared to existing information systems. 

The Washington Post
 Share with us your research, awards and accomplishments! 
Submit your news to Alaina Farrish at akfarrish@vcu.edu or (804) 628-4578.
Connect with us! 
Join Massey's online communities.
 Like us on Facebook  Follow us on Twitter  View our videos on YouTube